Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple MyelomaCLINICAL THERAPEUTICSIF3.62016-02-015PREAI
Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patientsHEMATOLOGICAL ONCOLOGYIF3.92013-04-1114PREAI
Clinical significance of sCD105 in angiogenesis and disease activity in multiple myelomaEUROPEAN JOURNAL OF INTERNAL MEDICINEIF6.12012-06-0116PREAI
B cell-activating factor: its clinical significance in multiple myeloma patientsANNALS OF HEMATOLOGYIF2.42012-04-2127PREAI
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myelomaCYTOKINEIF3.72011-12-0119PREAI
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myelomaHEMATOLOGICAL ONCOLOGYIF3.92011-09-1432PREAI
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myelomaJOURNAL OF HEMATOLOGY & ONCOLOGYIF40.42011-05-0818OAAI
Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to TreatmentMEDIATORS OF INFLAMMATIONIF4.22011-01-0118OAAI
Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myelomaCYTOKINEIF3.72007-02-0128PREAI
Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and MontenegroCLINICAL CHEMISTRY AND LABORATORY MEDICINEIF3.72006-01-010PREAI
Serum evaluation of angiogenic cytokines basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: Correlation with bone marrow microvascular densityINTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGYIF2.62005-04-0138OAAI
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone diseaseCLINICAL CHEMISTRY AND LABORATORY MEDICINEIF3.72005-01-0126OAAI